A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the ...

The following is a summary of “Vitamin D Status and Incidence of SARS-CoV-2 Reinfections in the Borriana COVID-19 Cohort: A ...

As the Trump administration continues to rattle swords with US science, we speak with Lisa Fazio of Vanderbuilt University who found out abruptly her funding from the National Science Foundation is ...

The following is a summary of “Effect of pre-existing coronavirus antibodies on SARS-CoV-2 infection outcomes in exposed household members,” published in the April 2025 issue of Journal of Infectious ...

The highest risk of transmission of SARS-CoV-2 was in the first 72 hours at room temperature and first 24 hours at 37℃.

The White House has revamped its COVID-19 website to support the lab leak theory, claiming the virus originated from a ...

Ensitrelvir was effective as post-exposure prophylaxis against COVID-19 if taken within 72 hours of exposure to SARS-CoV-2. The drug was granted fast-track designation by the FDA earlier this year.

A recent finding in Nature showed that the spike protein of SARS-CoV-2 binds with fibrinogen, leading to thrombo-inflammation. This raises a fundamental question: Why does the virus need to bind with ...

Although Africa has been qualified as having an unsatisfactory level of diagnosis in the face of this pandemic, our laboratory has nevertheless been able to carry out a large number of screening tests ...

By Dr. Liji Thomas, MD A study revealed that Jun13296, a novel PLpro inhibitor, demonstrates potent antiviral and anti-inflammatory effects in vivo, offering hope for future COVID-19 therapies beyond ...